OrbiMed Advisors LLC's Form 4 filing
Passage BIO, Inc. (PASG) · filed Jan 24, 2022
- Accession no.
- 0000947871-22-000090
- Filed
- Jan 24, 2022, 4:44 PM ET
- Trade date
- Jan 20, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $2.00M. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0000947871-22-000507 (May 5, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2022 | Common Stock | PPurchaseAcquired | +369,100 | $5.42F1 | +$2,000,522 | 6,634,723 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares of the Issuer's common stock ("Shares") were purchased in a block order at price of $5.60.
Referenced by the price of 1 transaction in Table I.